Clinics on Cloud: Pune-based startup brings Health ATMs to rural areas
Abhay Agarwal, founder and CEO of Clinics on Cloud, spoke about the urgent need to modernise rural healthcare. 'India's rural population often lacks access to timely diagnostic services, which delays treatment and increases health risks. Our Health ATM concept is designed to bridge this critical gap—bringing over 65 rapid diagnostic tests to the doorsteps of rural citizens,' he said. This comprehensive preventive health screening can be done in 10 minutes and can also help reduce medical costs, Agarwal added.
These AI-enabled Health ATMs can perform a wide array of health checks—from routine vitals and blood pressure to advanced screenings for diabetes, cardiac conditions, hemoglobin levels, and infectious diseases like dengue, malaria, Covid-19, and HIV. The tests include a general health check-up (body mass index, pulse, SPO2, body temperature, muscle mass, bone mass and so on), urine rapid test, ear and eye tests, pulmonary function tests among others. Reports are generated instantly, ensuring timely medical consultation through telemedicine, even in remote regions. Manashrri Agarwal, co-founder and Managing Director of Clinics on Cloud, added that the goal is to make preventive healthcare accessible, affordable, and accurate for every Indian—regardless of location.
'These Health ATMs have an accuracy rate of over 95% and operate at a fraction of the cost of traditional labs,' she said. In a unique collaboration with distribution partner DynaBlaze, Clinics on Cloud has engineered the Health ATMs to function without the need for electricity or internet, making them perfectly suited for deployment in electricity-deficient rural zones. The machines are available through EMI and rental options, also creating local employment opportunities by training health operators in villages.
Ajay Dhumane, spokesperson for DynaBlaze, said, 'This is more than a healthcare solution—it's a rural empowerment movement. By enabling easy ownership and operation of Health ATMs, we're nurturing rural entrepreneurship while transforming public health outcomes.' According to Agarwal, till date, over 80 lakh individuals have benefited from this initiative, with 3000 Health ATMs installed in 150+ Indian cities and seven international markets.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
14 minutes ago
- Hans India
DRDO, AIIMS Telangana unveil indigenous, low-cost prosthetic foot
New Delhi: In a first, Indian researchers from the Defence Research and Development Laboratory (DRDL) and AIIMS Bibinagar in Telangana have developed a low-cost prosthetic foot to boost mobility among people with limb loss, the Ministry of Defence said on Tuesday. The first made-in-India cost-effective advanced Carbon Fibre Foot Prosthesis was developed under the Aatmanirbhar Bharat initiative. It will help amputees from lower-income groups get access to good-quality prosthetics, as well as lower the production cost for prosthetics in the country. The new prosthetic foot is biomechanically tested to load up to 125 kg with sufficient safety factors. It also has three variants to cater to patients of different weights. 'This foot is designed with the goal of offering a high-quality and affordable solution accessible to a larger population in need while delivering performance at par with available international models,' the Ministry said. 'It is expected to reduce the cost significantly to as low as less than Rs 20,000 in production in comparison to the current imported similar products that cost around Rs two lakh,' it added. The need for foot prosthetics in India is significant, driven by a high incidence of limb loss due to accidents, medical conditions, and congenital disabilities. Prosthetics offer a crucial means to restore mobility and independence, but affordability and access remain major challenges for many individuals. High-quality prosthetics can be expensive, making them inaccessible to a large segment of the Indian population. Limited access to skilled prosthetists and rehabilitation centers, especially in rural areas, hinders the availability of prosthetic care. The new prosthetic foot is designed for highly dynamic K3-level active users offering high performance at an affordable cost. 'This innovation is expected to significantly improve accessibility to high-quality prosthetics for low-income group amputees in India, reduce dependency on imported technologies, and support broader social and economic inclusion for people with disabilities,' the Ministry said.
India Gazette
37 minutes ago
- India Gazette
Volgograd State Medical University Partners with Medanta Hospital to Offer Clinical Training Opportunities in India
SMPL New Delhi [India], July 15:In a landmark collaboration that bridges global medical education with Indian clinical excellence, Volgograd State Medical University (VSMU) has signed a Memorandum of Understanding (MoU) with India's renowned Medanta Hospital. The partnership will facilitate clinical internships and hands-on training opportunities for international MBBS students enrolled at VSMU, particularly benefiting Indian students pursuing their medical education in Russia. The agreement was formalized in India during the visit of Ms. Natalia Alshuk, Director of the International Department at VSMU. The collaboration aims to enhance practical exposure for medical students and aligns with the rising demand for globally oriented, practice-driven medical education. 'This is a significant step towards enabling our students to gain real-time experience in one of India's most advanced healthcare environments,' said Ms. Alshuk. 'It strengthens the academic-practice ecosystem and will inspire more Indian students to pursue their MBBS journey with us.' Founded in 1935, Volgograd State Medical University is ranked among the top 10 medical universities in Russia and currently hosts more than 2,000 international students. Known for its affordable education, modern infrastructure, and globally aligned curriculum, VSMU has consistently produced doctors and healthcare professionals who work across continents. AapkiUniversity, a leading education advisor with over a decade of experience in guiding students to pursue MBBS in Russia, played a key role in facilitating this partnership. The organization sees this MoU as a significant leap toward more relevant and job-ready medical education. 'At AapkiUniversity, we have been guiding students to pursue MBBS in Russia for over 10 years. With a strong commitment to excellence, we provide comprehensive support throughout their academic journey. From helping students choose the right university to offering in-depth insights and continuous academic assistance, we ensure they receive the best guidance every step of the way,' said a spokesperson from AapkiUniversity. This partnership addresses one of the biggest concerns for Indian MBBS aspirants studying abroad -- the need for structured clinical exposure and familiarity with Indian medical protocols. The opportunity to intern at Medanta, a globally recognized multispecialty hospital, is expected to significantly enhance the students' practical skills and post-graduate career readiness. The move is especially relevant as thousands of Indian students head overseas every year due to limited seats and high fees at private medical colleges in India. Russia, and specifically VSMU, has emerged as a top destination for Indian students because of its high academic standards, English-medium courses, and globally recognized degree. The VSMU-Medanta collaboration serves as a model for cross-border academic partnerships that are grounded in practical benefit rather than symbolic exchange. Students will now receive a globally grounded medical education with localized experience, equipping them to perform in diverse healthcare environments. As an active partner in this initiative, AapkiUniversity reiterated its role in not only facilitating admissions but also providing a 360-degree mentorship experience for students. This includes university selection, application guidance, visa assistance, pre-departure support, and now, access to clinical exposure opportunities. With this partnership, Volgograd State Medical University is not just offering an MBBS degree--it is delivering a career-ready, globally enriched medical experience. For aspiring doctors seeking both affordability and quality, this collaboration marks a powerful milestone. As international medical education continues to evolve, such meaningful collaborations will shape the future--ensuring that students receive the best of both worlds: global knowledge and local experience. To know more, visit: For more information visit: (ADVERTORIAL DISCLAIMER: The above press release has been provided by SMPL. ANI will not be responsible in any way for the content of the same)
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug
The Hyderabad-based drugmaker has been selected as one of the generic manufacturers under the expanded voluntary licensing agreement between the Medicines Patent Pool and ViiV Healthcare Press Trust of India Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic manufacturers under the expanded voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare, the company said in a statement. The agreement allows Aurobindo to manufacture and supply the long-acting injectable HIV treatment across 133 countries, including several low and middle-income markets, it added. This update now includes long-acting cabotegravir (CAB LA) for HIV treatment, in addition to its earlier use for prevention only. The treatment offers an alternative to daily pills, allowing patients to receive just one injection every one or two months. "We are privileged to be part of the sub-license expansion from MPP and ViiV to develop, manufacture, and distribute generic CAB LA in select markets for the treatment of HIV-1, in addition to the voluntary licence for PrEP," Aurobindo Pharma Vice Chairman & Managing Director K Nithyananda Reddy said. This is a significant and timely step towards increasing access to advanced long-acting treatment in LMICs, he added. Aurobindo remains committed to leveraging its global supply capabilities to make this vital combination long-acting injection therapy widely available and affordable, he stated. The consideration by ViiV and MPP to include the private market in royalty-bearing countries is a critical step toward expanding access across both public and private sectors, it added. ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool (MPP), have announced an update to their voluntary licensing agreement to include patents relating to its use in a long-acting regimen. The announcement follows updated guidance from the WHO recommending long-acting injectable cabotegravir + rilpivirine as an HIV treatment option. Existing generic licensees for prevention will be able to develop, manufacture and supply generic CAB LA, for use in combination with long-acting rilpivirine, subject to required regulatory approvals, to help enable access to the long-acting treatment in 133 countries worldwide. This includes all least-developed, low-income, lower middle-income, and Sub-Saharan African countries, as well as countries where ViiV does not have patent rights for cabotegravir.
